ECSP003679A - PIRIDINES AND SUBSTITUTED PYRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY - Google Patents

PIRIDINES AND SUBSTITUTED PYRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY

Info

Publication number
ECSP003679A
ECSP003679A ECSP003679A ECSP003679A EC SP003679 A ECSP003679 A EC SP003679A EC SP003679 A ECSP003679 A EC SP003679A EC SP003679 A ECSP003679 A EC SP003679A
Authority
EC
Ecuador
Prior art keywords
inhibition activity
substituted
ring
pyridacines
piridines
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Jacques Dumas
Harold Clinton Eugene Kluender
Ning Su
Stephen Boyer
Dhanapalan Nagarathnam
Julie A Cison
Teddy Kite Joe
Wendy Lee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003679 priority Critical patent/ECSP003679A/en
Publication of ECSP003679A publication Critical patent/ECSP003679A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Piridinas y piridacinas sustituidas que tienen actividad de inhibición de angiogénesis y la fórmula estructural generalizada: donde el anillo que contiene A, B, D, E, y L es fenilo o un heterociclo que contiene nitrógeno; los grupos X e Y pueden ser cualquiera de una variedad de unidades de enlace; R1 y R2 pueden ser sustituyentes independientes definidos o juntos pueden ser un puente que define un anillo; el anillo J puede ser un grupo arilo, piridilo o cicloalquilo; y los grupos G pueden ser cualquiera de una variedad de sustituyentes definidos. También se describen composiciones farmacéuticas que contienen estos materiales y los métodos de tratamiento de un mamífero que tiene un trastorno caracterizado por procesos de angiogénesis e hipermeabilidad anormales mediante el uso de estos materiales.Pyridines and substituted pyridazines that have angiogenesis inhibition activity and the generalized structural formula: where the ring containing A, B, D, E, and L is phenyl or a nitrogen-containing heterocycle; Groups X and Y can be any of a variety of link units; R1 and R2 can be defined independent substituents or together they can be a bridge defining a ring; the J ring may be an aryl, pyridyl or cycloalkyl group; and the G groups can be any of a variety of defined substituents. Pharmaceutical compositions containing these materials and the methods of treatment of a mammal having a disorder characterized by abnormal angiogenesis and hypermeability processes through the use of these materials are also described.

ECSP003679 2000-09-25 2000-09-25 PIRIDINES AND SUBSTITUTED PYRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY ECSP003679A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003679 ECSP003679A (en) 2000-09-25 2000-09-25 PIRIDINES AND SUBSTITUTED PYRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003679 ECSP003679A (en) 2000-09-25 2000-09-25 PIRIDINES AND SUBSTITUTED PYRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY

Publications (1)

Publication Number Publication Date
ECSP003679A true ECSP003679A (en) 2001-06-22

Family

ID=42041273

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003679 ECSP003679A (en) 2000-09-25 2000-09-25 PIRIDINES AND SUBSTITUTED PYRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY

Country Status (1)

Country Link
EC (1) ECSP003679A (en)

Similar Documents

Publication Publication Date Title
DOP2000000070A (en) PIRIDINES AND REPLACED PIRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY
ATE264846T1 (en) SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR TREATING RETROVIRAL INFECTIONS
ES2080900T3 (en) PYRANIC DERIVATIVES USEFUL AS 5-LIPOXIGENASE INHIBITORS.
ATE269850T1 (en) 3-THIOCARBAMOYLPYRAZOLE DERIVATIVES AS PESTICIDES
ES2079576T3 (en) BICYCLE PYRANIC DERIVATIVES AND THEIR USE AS 5-LIPOXIGENASE INHIBITORS.
TR200002480T2 (en) Guanidine derivatives for the treatment of izazemi
CO5050295A1 (en) GLUCOKINASA TRANS OLEFINAL ACTIVATORS
ES2117400T3 (en) METALOPROTEINASE INHIBITORS.
TR200101858T2 (en) 4-aryloxindoles as JNK protein kinase inhibitors
BR0016034A (en) Organic compounds
PT1200426E (en) TIENO-3-IL-SULFONYLAMINO (TIO) CARBONYL-TRIAZOLINE (TI) SUBSTITUTED ONES
ATE168102T1 (en) 1,4-BENZODIAZEPINE DERIVATIVES AND THEIR USE AS CCK MODULATORS
AR027296A1 (en) DERIVATIVES OF 4-HETEROARIL-1,4-DIAZABICICLO [3.2.2] NONANO, ITS PREPARATION AND THERAPEUTIC APPLICATION
NO954576L (en) AMPA antagonists and a method of treating them
ES384015A1 (en) Heterocyclic-substituted n-imidazol plant-growth influencing agents
DK0678090T3 (en) piperazine
FI956300A0 (en) pyridazinone
FI923540A0 (en) ARYLALKYLAMINER OCH -AMIDER MED ANTIKONVULSIVA OCH NERVSKYDDANDE EGENSKAPER.
ECSP003679A (en) PIRIDINES AND SUBSTITUTED PYRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY
DK1717229T3 (en) New cyclic compound with 4-pyridylalkylthio group with substituted amino (therein) substituted
UY34282A (en) PIRIDACINAS REPLACED WITH ANGIOGENESIS INHIBITION ACTIVITY
AR043271A1 (en) DIHYDROPIRONAS COMPOUNDS WITH UNITED HETEROCICLES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS THAT HAVE HIV PROTEASA INHIBITING ACTIVITY
ES2149193T3 (en) HETEROCICLIC COMPOUNDS REPLACED WITH RENT.
CO4940478A1 (en) DERIVATIVES OF 1- (2-ACILIMIDAZOL-1-ILALQUIL) QUINUCLIDINO
AR045154A1 (en) 1,4-DISPOSED PIPERIDINIC COMPOUNDS, THEIR PREPARATION, COMPOSITIONS CONTAINING THEM, AND THEIR USE